Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
about
Diagnosis and management of somatosensory tinnitus: review article.Botulinum toxin A for the Treatment of Overactive BladderDevelopment of onabotulinumtoxinA for chronic migraineBotulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerationsEmerging treatments for overactive bladder: clinical potential of botulinum toxins.Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.Universal and specific quantitative detection of botulinum neurotoxin genesEffects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctionsA multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraineThe prophylactic treatment of chronic daily headache.Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injuryExploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.OnabotulinumtoxinA for chronic migraine: a critical appraisal.Insights into the mechanism of onabotulinumtoxinA in chronic migraine.Effects of OnabotulintoxinA on Habituation of Laser Evoked Responses in Chronic MigraineAcupoint injection of onabotulinumtoxin A for migraines.Botulinum toxin type A for the treatment of migraine.Long term effects of intra-articular botulinum toxin A for refractory joint pain.Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.Onabotulinumtoxin A for treating overactive/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningoceleThe structure and mode of action of different botulinum toxins.Is there hope for chronic pain and headache?A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine/Depomedrol injection on residual and phantom limb pain: initial report.Botulinum toxin type a therapy in migraine: preclinical and clinical trials.OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine.Botulinum Toxin in Migraine Treatment.Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxins.Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults.Pharmacotherapy in pediatric neurogenic bladder intravesical botulinum toxin type a.Efficacy and safety of botulinum toxin A intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic review.A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity.OnabotulinumtoxinA for the treatment of headache.Glutamate receptor antagonists in the management of migraine.Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central Sensitization.Urethral Sphincter Injection of Botulinum Toxin A: A Review of Its Application and Outcomes.Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis.Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome.
P2860
Q22241467-9DEF417B-2EE2-4C56-9212-6B37F201324EQ26764765-49C7189B-5AEF-4457-B475-2B3A2DB948E6Q27027006-04D902AF-F821-4F16-884E-E178007F7B0EQ28194984-3178D9FC-8FC4-4950-9C29-548B6B325B48Q33689757-9FB8DDBF-5D39-4444-AA0A-0A9133832DCEQ33723150-37574BC2-3678-46E6-B830-9F8AE4D86BABQ33723538-4002A98C-F417-4F52-8894-B53F02C26A2DQ33839272-C4DB8A67-37D2-4291-8A1F-18AD5E1EB574Q34003508-1C68C4EF-68D2-4F0E-8A55-FD8E4A33BCF3Q34154494-DAD84770-4777-4011-B429-23EB4738D23DQ34521929-D188BAFD-50B1-40F7-805A-2D5633F8947AQ34583067-42F8D318-8893-48B2-BC33-D6CB335E313BQ35006462-9E15FB79-7D6C-4C1F-B12C-C2927490040BQ35697217-2212B1B8-0C5B-4199-B23E-A1C88FC24CA7Q35822040-3F7F45B4-C32D-44E7-85B3-10F087BA9878Q35837340-4C96047C-B10B-4035-8F99-F376BD806D0DQ36032213-AD6554B6-6425-466A-89C5-9330AE335220Q36329577-0823D20D-CC9D-4523-9201-44A11FAF4F36Q36488226-31BF28EA-8C6E-4275-9E93-34B3CA8524DCQ36511613-C35D887A-2FCC-4078-AE6D-B32D0655FA91Q36518248-8F08831C-9450-4D6C-95DA-EFCC3CD1F4DDQ36586729-E16DDBA7-A93F-4957-BDD6-3B6F139A28B8Q36656462-CD6E6D4B-5962-4D1D-9D13-63679B4BB5BBQ36947170-94EE698D-DE7C-4A81-AFAF-EF6BE41FD9CFQ37353529-FDEB44EE-C4FA-4B2A-972F-D417C6069F01Q37631993-C481A9E2-C53B-4232-892D-FAC1A708D058Q37678415-164C521E-C56C-4CB5-AFD3-C4688BFFACB4Q37703847-A4B5057C-D2B9-4DCA-98B6-06A9B6187FBDQ37834654-F6E9585A-19BD-43B3-BD17-8E97223A70D1Q37946313-91B9C891-014D-4114-9B21-CF62355DA285Q38020486-EFB3033F-4845-4C67-AB8F-86664EC2C33CQ38115204-2E62D873-3C8B-4629-BB2D-28D5DED8E4DDQ38115299-0DE66E0F-DF41-40BA-A13F-F365BCE23408Q38136258-53D0C18B-B6CB-46BF-8D46-39A76D140EE6Q38230246-42888C89-6221-42CE-A247-3EF9332092C1Q38731392-88C652A0-C8F5-4592-A6E8-877556228D0FQ38873658-17058127-6A9A-41C6-A276-C00E72C9C262Q39146316-D214F930-C639-40F2-AA76-5F903091D308Q39210488-61BF1DE5-BE3F-45EB-B52D-45EAEFC8C447Q39290094-8D33CD8D-077B-4415-A15E-9D986C917525
P2860
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@ast
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@en
type
label
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@ast
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@en
prefLabel
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@ast
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@en
P2860
P1433
P1476
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
@en
P2093
Oliver Dolly
P2860
P304
P356
10.1046/J.1526-4610.43.7S.4.X
P478
43 Suppl 1
P577
2003-07-01T00:00:00Z